A Comprehensive Peer Mentor-based Disease Management Program for Medically Complex Substance Users

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.

Verified October 2009 by Johns Hopkins University.
Recruitment status was: Not yet recruiting

Sponsor:

Collaborator:

Healthways, Inc.

Information provided by:

Johns Hopkins University

ClinicalTrials.gov Identifier:

NCT00993395

First received: October 9, 2009

Last updated: NA

Last verified: October 2009

History: No changes posted

Purpose

Substance-using adults are admitted to hospital for medical complication from their drug and alcohol use at very high rates; yet, their care is often defined by low rates of referral to addiction treatment programs and recidivism. In 1997, we instituted an integrated medical-substance use treatment program at Johns Hopkins, the First Step Day Hospital, designed for intensive post-acute care of previously hospitalized substance using adults. We have shown that patients with dual diagnoses admitted to First Step more often complete their course of medical care and stay in recovery longer than patients not admitted to First Step.(1;2) On discharge from First Step, patients are medically stable and drug-free. Their substance abuse care is transferred to an out-patient substance abuse treatment facility and their medical care is transferred to their primary care provider. Unfortunately, many patients are lost to follow-up during this transition. We believe that a peer mentor-based disease management program (PM) can provide continuity of care that begins in First Step and continues after discharge thereby increasing the proportion of patients who remain in treatment for their addiction and medical conditions. Peer mentors are persons from the target community who have been in recovery for 5 or more years. In cooperation with patients and providers, peer mentors improve the integration of care, quality of care, and access to healthcare services. This pilot study will test the effectiveness of a peer mentor-based disease management program. The specific aims are to compare the impact of the PM intervention verses enhanced usual care on outcomes in three domains (1) medical/psychiatric health status, (2) addiction recovery, and (3) social resource acquisition. If successful, this study will provide evidence supporting a larger randomized controlled trial of the impact of field workers on post-acute care among patients with dual diagnoses.

Condition	Intervention
Substance Addiction	Behavioral: peer mentor-based disease management


Study Type:	Interventional
Study Design:	Allocation: Non-Randomized Intervention Model: Parallel Assignment Masking: Open Label Primary Purpose: Supportive Care
Official Title:	A Comprehensive Peer Mentor-based Disease Management Program for Medically Complex Substance Users

Further study details as provided by Johns Hopkins University:

Primary Outcome Measures:

adherence to first prescription refill after discharge [ Time Frame: 60 days ]

Secondary Outcome Measures:

Adherence to first medical appointment [ Time Frame: 60 days ]
Rate of readmission and emergency department visits [ Time Frame: 3 years ]
Length of stay in a recovery program [ Time Frame: 1 year ]
Number of days without substance use [ Time Frame: 3 years ]
Acquisition of medical insurance [ Time Frame: 1 year ]
acquisition of long-term housing [ Time Frame: 3 years ]
Acquisition of financial support [ Time Frame: 3 years ]


Estimated Enrollment:	160
Study Start Date:	January 2010
Estimated Study Completion Date:	December 2013
Estimated Primary Completion Date:	December 2013 (Final data collection date for primary outcome measure)

Arms	Assigned Interventions
Experimental: Peer Mentor Intervention peer mentor-based disease management focusing on three domains: medical care, recovery, and social stabilization	Behavioral: peer mentor-based disease management peer mentor-based disease management focused on three domains: medical care, recovery, and social stabilization

Eligibility


Ages Eligible for Study:	Child, Adult, Senior
Sexes Eligible for Study:	All
Accepts Healthy Volunteers:	No

Criteria

Inclusion Criteria:

All patients admitted to an intensive day hospital focused on medically complex substanse users are eligible for enrolment

Exclusion Criteria:

Inability to provide informed consent

Contacts and Locations

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00993395

Contacts


Contact: Noreen Krause, BS	4109553753	nkrause1@jhmi.edu

Locations


United States, Maryland
Johns Hopkins Hospital	Not yet recruiting
Baltmore, Maryland, United States, 21287
Contact: J H Young, MD, MHS 410-502-5808 jhyoung@jhmi.edu
Sub-Investigator: Anika H. Alvanzo, MD, MS

Sponsors and Collaborators

Johns Hopkins University

Healthways, Inc.

More Information


Responsible Party:	Jeffery Hunter Young, Assistant Professor, Johns Hopkins University
ClinicalTrials.gov Identifier:	NCT00993395 History of Changes
Other Study ID Numbers:	NA_00020931
Study First Received:	October 9, 2009
Last Updated:	October 9, 2009

Keywords provided by Johns Hopkins University:


addiction peer mentor adherence

Additional relevant MeSH terms:


Behavior, Addictive Substance-Related Disorders Compulsive Behavior	Impulsive Behavior Chemically-Induced Disorders Mental Disorders

ClinicalTrials.gov processed this record on August 16, 2017

To Top